Skip to main content
. Author manuscript; available in PMC: 2009 Oct 1.
Published in final edited form as: Cancer Res. 2008 Oct 1;68(19):7915–7922. doi: 10.1158/0008-5472.CAN-08-0766

Table 1.

Frequency of myeloproliferation, lymphoma and other malignancies

Myeloproliferation Lymphoma Other malignancies* Total Myeloid hyperplasia
WT Control 0/20(0) 0/20(0) 0/20(0) 0/20(0) 0/20(0)
NQO1-/- Control 0/19(0) 0/19(0) 3/19(16) 3/19(16) 15/19(79)
WT 1gy 0/20(0) 0/20(0) 0/20(0) 0/20(0) 0/20(0)
NQO1-/- 1gy 4/18(22) 3/18(17) 9/18(50) 13/18(72) 16/18(89)
WT 3gy 0/19(0) 2/19(11) 0/19(0) 2/19(11) 4/19(21)
NQO1-/- 3gy 14/19(74) 6/19(32) 16/19(84) 18/19(95) 19/19(100)
*

Most other malignancies were lung adenocarcinoma.

Numbers in parenthesis show the percentage of mice with myeloproliferation, lymphoma, other malignancies, total malignancies and myeloidhyperplasia.